Rakovina to Present at the 2022 Annual Meeting of the American Association of Cancer Research (AACR)
Rakovina Therapeutics presentation will highlight pre-clinical research related to its novel kt-4000 series.
© 2023 Frontier Merchant Capital Group. All Rights Reserved.